Navigation Links
WeissComm Partners Promotes Diane Weiser to President and Chief Operating Officer
Date:3/25/2008

NEW YORK and SAN FRANCISCO, March 25 /PRNewswire/ -- WeissComm Partners, Inc., the fastest growing independent public relations firm in the United States, today announced the promotion of Diane Weiser to President and Chief Operating Officer. She will continue to report to WeissComm's founder and CEO, Jim Weiss, who also will become Chairman.

Since Weiser joined WeissComm in August 2004, the firm has quadrupled its revenues to $16.5 million and the number of employees to more than 75, grown its New York office, opened offices in Chicago and Washington, D.C., and established an international presence and capability.

"Diane has successfully applied more than 20 years of healthcare communications experience to WeissComm's diverse portfolio of innovative biotechnology, pharmaceutical, healthcare services, device and diagnostic clients," Weiss said. "She has taken WeissComm to a higher level with her commitment to quality and preservation of our unique independent, entrepreneurial culture, her no-nonsense, direct management style, attention to detail and thoughtful infrastructure development. In this much-deserved new role, Diane will help lead WeissComm into our next exciting phase of growth and expansion."

Prior to joining WeissComm, Weiser was director of the healthcare practice in the San Francisco office of Ketchum. In that position, she led the Genentech Avastin(R) business, managing a multi-office Best Team for the account, as well as providing counsel to other Genentech product teams. Prior to Ketchum San Francisco, Diane ran Ketchum's New York healthcare practice, which was the lead agency for the global Lipitor(R) business. She has developed and managed strategic, high-profile programs for leading pharmaceutical and biotechnology companies including Pfizer, Roche, Bayer Diagnostics, Allergan, Aventis, Celgene Corporation and Pharmacia.

About WeissComm Partners

WeissComm Partners, Inc. is a full-service public relations
'/>"/>

SOURCE WeissComm Partners, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. WeissComm Partners Names Tom Jones Managing Director to Deepen Global Product Communications Offering
2. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
3. Kagome Partners With Raise the Hope to Fight Heart Disease
4. HealthMEDX Partners With Silverchair Learning Systems
5. Turner Investment Partners Added to AHA Diversified Equity Fund
6. Vista Partners Initiates Coverage on Arana Therapeutics (ASX: AAH; AIM: AAHx)
7. ACM Partners With Tufts Associated Health Plans to Improve the Cost-effective Delivery of Home Infusion Services
8. Medicine Disposal Partnership Will Encourage Public to Flush Less, Crush More
9. Country Music Star Troy Gentry Partners With National Non-Profit Patient Advocate Foundation to Spread the Message About Challenges to Healthcare Access for Insured and Uninsured Americans
10. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
11. Quaker(R) Life(R) Cereal Partners with Actress and Mom Holly Robinson Peete to Inspire Moms to Make Their Best Days Happen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...onal Pediatric AIDS Initiative Will Improve... WASHINGTON, Aug. 29 /PRNewswire-FirstCall/ -- Th... government, Baylor College of Medicine, the,gover...S. President,s,Emergency Plan for AIDS Relief (PEP... improve care and treatment for children with HIV/...
(Date:8/29/2008).../ -- Conseco Insurance Company, a life,and health ...y of its new,indexed universal life insurance pro...de potential with downside protection., ConsecoLi... offers the,opportunity for long-term cash buildup...ents can customize their coverage levels with eigh...
(Date:8/29/2008)...SNewswire/ -- The U.S. Department of,Labor propose...public to,see exactly what goes into agency risk a...r http://edocket.access.gpo.gov/2008/E8-20179.htm...st available evidence and,scientific data are used...ards regulating occupational exposure to toxins in...
(Date:8/29/2008)...SNewswire/ -- The following is a,statement by Matt... Kids:, For the second time in a month, Philip Mo... and promotion of a concert in a developing countr...ngaging in cigarette,marketing that appeals to chi...s been forced to withdraw from,an August 30 reunio...
Breaking Medicine News(10 mins):Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 2Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 3Health News:Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 4Health News:ConsecoLifeOptions Launched by Conseco Insurance Company as New Universal Life Product 2Health News:Notice of Proposed Rulemaking on U.S. Department of Labor's Risk Assessment Procedures Published in Federal Register 2Health News:Philip Morris International Forced to Drop Another Concert Sponsorship; Philippines Health Department Applauded for Taking Action 2
...The US government does not have a precise figure o...fghanistan. The death toll is relatively easy to... the case of the wounded estimates vary, between 3...important the precise numbers it is the lack of pr...
...Harry Potter author JK Rowling is strengthening he...led children in East European mental hospitals, af...ng is carrying on her campaign to bring an end to ...dren kept in cages in institutions in East Europe....
...The coming summer vibrates with expressions of ins...terflies' bright colours are examples of how an em...sponding sex. Moth odours (pheromones), though les... which females guide males towards them, even on t...
...Canadian funny man Jim Carreys lady love Jenny McC...y tan this summer . The actress insisted that the ...n the beach. "Beach beach beach beach beach. We l... and do nothing. Stare at the ocean and go 'ohhmmm...
Other Medicine News:Health News:US Trying Hard to Provide Proper Treatment for Wounded Soldiers 2Health News:US Trying Hard to Provide Proper Treatment for Wounded Soldiers 3Health News:US Trying Hard to Provide Proper Treatment for Wounded Soldiers 4Health News:JK Rowling Intensifies Her Disabled Children's Rights Crusade 2Health News:Another Sexual Attraction is Possible ... 2
(Date:8/27/2008)...of Bucks, Delaware, Montgomery,Philadelphia Count...ire/ -- After encouraging,results following the fi...Environmental Protection will continue its efforts...squito-borne West Nile virus., Targeted aerial tr...idnight in portions of Bucks, Delaware, Montgomery...
(Date:8/27/2008)...an and prednisone arm demonstrated a, significant... response -, CAMBRIDGE, Mass., Aug. 27 /PRNewswir...y announced the publication of results from the 68... this week,s edition of the,New England Journal of...al,benefit and a 30 percent complete remission (CR...
(Date:8/27/2008)...wire-FirstCall/ --, - Oralair(R) Grasses 300IR Hi...c Study Conducted in an Allergen Challenge Chamber... results of a new study,conducted in an Allergen C...Grasses included 86 adult patients exposed to,gras...ons: 1 week, 1 month,2 and 4 months without a tit...
(Date:8/27/2008)...-52 trial, expected by mid-2009 - - Data from sec... -, ROCKVILLE, Md., Aug. 27 /PRNewswire-FirstCall...today announced it has completed enrollment,and in...l Phase 3,randomized clinical trials of LymphoStat... lupus erythematosus (SLE). Belimumab is being dev...
Breaking Medicine Technology:DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 2DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 2New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 3New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 4New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 5New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients 6Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Leading Natural Cosmetics Company Supports Breast Cancer Survivors 13433 1Leading Natural Cosmetics Company Supports Breast Cancer Survivors 13433 2Leading Natural Cosmetics Company Supports Breast Cancer Survivors 13433 3Leading Natural Cosmetics Company Supports Breast Cancer Survivors 13433 4Scientists find mercury threatens next generation of loons 13432 1Scientists find mercury threatens next generation of loons 13432 2New potential drug target for the treatment of atherosclerosis 13430 1New potential drug target for the treatment of atherosclerosis 13430 2New potential drug target for the treatment of atherosclerosis 13430 3Smith 26 Nephew Announces Breakthrough VERILAST 28TM 29 Technology 13428 1Smith 26 Nephew Announces Breakthrough VERILAST 28TM 29 Technology 13428 2Smith 26 Nephew Announces Breakthrough VERILAST 28TM 29 Technology 13428 3Smith 26 Nephew Announces Breakthrough VERILAST 28TM 29 Technology 13428 4
...nt Therapy Significantly,Improved Absorption of Fa... and DAYTON, Ohio, April 04, 2007 /PRNewswire/ --,... today unveiled,data from two phase III clinical t...formerly EUR-1008, for the treatment of,Exocrine P...g,Administration (FDA) granted fast track status f...
...2007 - CytRx Corporation,(NASDAQ:CYTR) today annou...studies indicating that CytRx,s lead drug candidat...ry of sensory and,motor function in an experimenta...hheld as long as 48 hours after stroke was,induced...ata,announced by CytRx in December 2006. Orally-ad...
Other Medicine Technology:Eurand Announces Positive Phase III Clinical Study Results 2Eurand Announces Positive Phase III Clinical Study Results 3Eurand Announces Positive Phase III Clinical Study Results 4Eurand Announces Positive Phase III Clinical Study Results 5CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 2CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 3CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 4CytRx Announces Positive Results of Arimoclomol in Preclinical,Stroke Recovery Studies 5
The EZY Close post op shoe's flap-on-flap closure provides a secure fit and can accommodate even the bulkiest of dressing. Perfect for older patients with limited hand dexterity.
This popular post op shoe provides quality care at an outstanding value. The semi-rigid outsole provides stability and minimizes flexure.
...for patients who experience severe plantar fasciit... fibrous tissue that can occur after rest periods ...ing. The continuous tension and fixed position red...d helps stretch the Achilles tendon to provide rel...
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
Medicine Products: